Edwards Lifesciences Corporation Tax Adjustments, Settlements, and Unusual Provisions
Edwards Lifesciences Corporation (EW) reported Tax Adjustments, Settlements, and Unusual Provisions of $262.10 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-02-17.
Discontinued › Notes › Income Taxes
us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions · last filed 2017-02-17
- Edwards Lifesciences Corporation tax adjustments, settlements, and unusual provisions for the quarter ending 2012-09-30 was $0.00.
- Edwards Lifesciences Corporation tax adjustments, settlements, and unusual provisions for the quarter ending 2012-06-30 was $0.00, a 100.00% decline year-over-year.
- Edwards Lifesciences Corporation tax adjustments, settlements, and unusual provisions for the quarter ending 2012-03-31 was -$2.30M.
- Edwards Lifesciences Corporation tax adjustments, settlements, and unusual provisions for the quarter ending 2011-09-30 was -$6.90M.
- Edwards Lifesciences Corporation tax adjustments, settlements, and unusual provisions for fiscal 2014 was $262.10M.
| Period end | Tax Adjustments, Settlements, and Unusual Provisions 3 month | Tax Adjustments, Settlements, and Unusual Provisions 3 month as first filed | Tax Adjustments, Settlements, and Unusual Provisions 6 month | Tax Adjustments, Settlements, and Unusual Provisions 6 month as first filed | Tax Adjustments, Settlements, and Unusual Provisions 9 month | Tax Adjustments, Settlements, and Unusual Provisions 12 month |
|---|---|---|---|---|---|---|
| 2014-12-31 | $262.10M 10-K · filed 2017-02-17 | |||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | -$2.30M 10-Q · filed 2013-11-07 | |||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$2.30M 10-Q · filed 2013-08-06 | $2.30M 10-Q · filed 2012-08-07 | |||
| 2012-03-31 | -$2.30M 10-Q · filed 2013-05-06 | $2.30M 10-Q · filed 2012-05-09 | ||||
| 2011-09-30 | -$6.90M 10-Q · filed 2012-11-07 | -$4.40M derived: sum of 2 quarters · filed 2012-11-07 | -$9.40M 10-Q · filed 2012-11-07 | |||
| 2011-06-30 | $2.50M 10-Q · filed 2012-08-07 | -$2.50M 10-Q · filed 2011-08-08 | $2.50M 10-Q · filed 2012-08-07 | -$2.50M 10-Q · filed 2011-08-08 | ||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$9.80M derived: sum of 2 quarters · filed 2011-11-08 | -$9.80M 10-Q · filed 2011-11-08 | |||
| 2010-06-30 | -$9.80M 10-Q · filed 2011-08-08 | -$9.80M 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |